ACRV
STRONGAcrivon Therapeutics, Inc.
CIK: 0001781174
Buy
(50% confidence)
Last activity: Jan 14, 2026
Financial Metrics
As of Sep 30, 2025 (10-Q)
Total Cash $36.02M
Current Ratio 9.80
Trend Signals
CEO Buy STRONG
CEO buying activity
Jan 14, 2026
CFO Buy STRONG
CFO buying activity
Jan 14, 2026
Insider Roster (3 total, 3 active)
| Insider | Buys | Sells | Net Value | Holdings |
|---|---|---|---|---|
| Blume-Jensen Peter President and CEO | 1 | 0 | $82K | 2,095,771 shares $3.51M |
| Devroe Eric Chief Operating Officer | 1 | 0 | $17K | 75,308 shares $130K |
| Levy Adam D. Chief Financial Officer | 1 | 0 | $15K | 20,983 shares $36K |
Recent Transactions
BUY Blume-Jensen Peter (President and CEO)
49,000 shares @ $1.68
$82K
Jan 14, 2026
Conviction: |
View SEC Filing →
BUY Levy Adam D. (Chief Financial Officer)
8,832 shares @ $1.70
$15K
Jan 14, 2026
Conviction: |
View SEC Filing →
BUY Devroe Eric (Chief Operating Officer)
10,000 shares @ $1.72
$17K
Jan 13, 2026
Conviction: |
View SEC Filing →
⚠️ Important Disclaimer
• This is AI-generated analysis for educational purposes only, not financial advice.
• Insider trading data is derived from SEC Form 4 filings and may contain errors.
• Always conduct your own research and consult qualified financial advisors before making investment decisions.